Search results
Michelle Quay is Lecturer of Persian at Brown and holds a doctorate in Asian & Middle Eastern Studies from Pembroke College, University of Cambridge. She also holds an M.A. from the University of California, Los Angeles, and is an alumna of the University of Chicago, where she received her B.A. with honors.
Dr. Steven Quay is the founder and CEO of Seattle-based Atossa Therapeutics (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics for breast cancer and other breast conditions.
Jul 15, 2021 · Dr. Steven Quay has 360+ published contributions to medicine and has been cited over 10,000 times, placing him in the top 1% of scientists worldwide. He holds 87 US patents and has invented seven FDA-approved pharmaceuticals which have helped over 80 million people.
Dr. Quay is a named inventor on 87 U.S. patents, 130 pending U.S. patent applications, and is named inventor on patents covering five pharmaceutical products that have been approved by the U.S. Food and Drug Administration.
Every 15 seconds, over 2 million times a year, a woman is diagnosed with breast cancer. Watch Dr. Quay’s TEDx talk on his decade long quest to prevent breast.
Jun 20, 2024 · Stay updated on the latest media coverage featuring Dr. Steven Quay’s groundbreaking work in biotechnology and medical research. Explore recent news articles and press releases highlighting Dr. Quay’s contributions, from his insights on breast cancer therapeutics to his expertise in understanding infectious diseases like COVID-19.
Apr 9, 2020 · Scott Taylor talks to Dr. Quay from Atossa Therapeutics about his clinical trial that will look at two drugs already approved by the FDA to battle COVID-19. ...
- 6 min
- 881
- TAYLOR NATION TV
Find the deal you deserve on eBay. Discover discounts from sellers across the globe. We've got your back with eBay money-back guarantee. Enjoy Dr who tv series you can trust.
